-
1
-
-
0035450305
-
125I brachytherapy
-
125I brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 51, 31-40 (2001).
-
(2001)
Int. J. Radiat. Oncol., Biol., Phys.
, vol.51
, pp. 31-40
-
-
Grimm, P.D.1
Blasko, J.C.2
Sylvester, J.E.3
Meier, R.M.4
Cavanagh, W.5
-
2
-
-
0034000423
-
Palladium-103 brachytherapy for prostate carcinoma
-
J. C. Blasko, P. D. Grimm, J. E. Sylvester, K. R. Badiozamani, D. Hoak, and W. Cavanagh, "Palladium-103 brachytherapy for prostate carcinoma," Int. J. Radiat. Oncol., Biol., Phys. 46, 839-850 (2000).
-
(2000)
Int. J. Radiat. Oncol., Biol., Phys.
, vol.46
, pp. 839-850
-
-
Blasko, J.C.1
Grimm, P.D.2
Sylvester, J.E.3
Badiozamani, K.R.4
Hoak, D.5
Cavanagh, W.6
-
3
-
-
0028919251
-
Dosimetry of interstitial brachytherapy sources: Recommendation of the AAPM radiation therapy committee task group no. 43
-
R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendation of the AAPM radiation therapy committee task group no. 43," Med. Phys. 22, 209-234 (1995).
-
(1995)
Med. Phys.
, vol.22
, pp. 209-234
-
-
Nath, R.1
Anderson, L.L.2
Luxton, G.3
Weaver, K.A.4
Williamson, J.F.5
Meigooni, A.S.6
-
4
-
-
0032891406
-
Guidance to users of Nycorred Amersham and North American Scientific, Inc., I-125 interstitial sources: Dosimetry and calibration changes: Recommendations of the American Associate of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry
-
J. F. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, R. Nath, and G. Ibbott, "Guidance to users of Nycorred Amersham and North American Scientific, Inc., I-125 interstitial sources: Dosimetry and calibration changes: Recommendations of the American Associate of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry," Med. Phys. 26, 570-573 (1999).
-
(1999)
Med. Phys.
, vol.26
, pp. 570-573
-
-
Williamson, J.F.1
Coursey, B.M.2
Dewerd, L.A.3
Hanson, W.F.4
Nath, R.5
Ibbott, G.6
-
5
-
-
0034004512
-
103Pd Interstitial Source Calibration and Dosimetry: Implications for dose specification and prescription
-
103Pd Interstitial Source Calibration and Dosimetry: Implications for dose specification and prescription," Med. Phys. 27, 643 (2000).
-
(2000)
Med. Phys.
, vol.27
, pp. 643
-
-
Williamson, J.F.1
Coursey, B.M.2
Dewerd, L.A.3
Hanson, W.F.4
Nath, R.5
Rivard, M.J.6
Ibbott, G.7
-
6
-
-
3042645234
-
Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy
-
M. K. Murphy, R. K. Piper, L. R. Greenwood, M. G. Mitch, P. J. Lamperti, S. M. Seltzer, M. J. Bales, and M. H. Phillips, "Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy," Med. Phys. 31, 1529-1538 (2004).
-
(2004)
Med. Phys.
, vol.31
, pp. 1529-1538
-
-
Murphy, M.K.1
Piper, R.K.2
Greenwood, L.R.3
Mitch, M.G.4
Lamperti, P.J.5
Seltzer, S.M.6
Bales, M.J.7
Phillips, M.H.8
-
7
-
-
0026651166
-
Permanent implants using Au-198, Pd-103, and I-125: Radiobiological considerations based on the linear quadratic model
-
C. C. Ling, "Permanent implants using Au-198, Pd-103, and I-125: Radiobiological considerations based on the linear quadratic model," Int. J. Radiat. Oncol., Biol., Phys. 23, 81-87 (1992).
-
(1992)
Int. J. Radiat. Oncol., Biol., Phys.
, vol.23
, pp. 81-87
-
-
Ling, C.C.1
-
8
-
-
0037035357
-
103Pd prostate permanent seed implants - A biomathematical model
-
103Pd prostate permanent seed implants-A biomathematical model," Phys. Med. Biol. 47, 1185-1204 (2002).
-
(2002)
Phys. Med. Biol.
, vol.47
, pp. 1185-1204
-
-
Yue, N.J.1
Chen, Z.2
Nath, R.3
-
9
-
-
0021812109
-
The application of the linear-qualratic dose-effect equation to fractionated and protracted radiotherapy
-
R. G. Dale, "The application of the linear-qualratic dose-effect equation to fractionated and protracted radiotherapy," Br. J. Radiol. 58, 515-528 (1985).
-
(1985)
Br. J. Radiol.
, vol.58
, pp. 515-528
-
-
Dale, R.G.1
-
10
-
-
0024550508
-
Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model
-
R. G. Dale, "Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model," Br. J. Radiol. 62, 241-244 (1989).
-
(1989)
Br. J. Radiol.
, vol.62
, pp. 241-244
-
-
Dale, R.G.1
-
11
-
-
0018320349
-
Dose-rate effects in mammalian cells in culture. III Comparison of cell killing and cell lines
-
J. B. Mitchell, J. S. Bedford, and S. M. Barley, "Dose-rate effects in mammalian cells in culture. III Comparison of cell killing and cell lines," Radiat. Res. 79, 537-551 (1979).
-
(1979)
Radiat. Res.
, vol.79
, pp. 537-551
-
-
Mitchell, J.B.1
Bedford, J.S.2
Barley, S.M.3
-
12
-
-
1142304255
-
Update of AAPM task group no. 43 report: A revised AAPM protocol for brachytherapy calculations
-
M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, "Update of AAPM task group no. 43 report: A revised AAPM protocol for brachytherapy calculations," Med. Phys. 31, 633-674 (2004).
-
(2004)
Med. Phys.
, vol.31
, pp. 633-674
-
-
Rivard, M.J.1
Coursey, B.M.2
Dewerd, L.A.3
Hanson, W.F.4
Huq, M.S.5
Ibbott, G.S.6
Mitch, M.G.7
Nath, R.8
Williamson, J.F.9
-
13
-
-
0032527941
-
103Pd prostate brachytherapy and its impact on post-implant dosimetry: An analysis based on serial CT acquisition
-
103Pd prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition," Int. J. Radiat. Oncol., Biol., Phys. 41, 1069-1077 (1998).
-
(1998)
Int. J. Radiat. Oncol., Biol., Phys.
, vol.41
, pp. 1069-1077
-
-
Waterman, F.M.1
Yue, N.2
Corn, B.W.3
Dicker, A.P.4
-
14
-
-
0037215315
-
How low is the α/beta; ratio for prostate cancer?
-
J. Z. Wang, M. Cuerrero, and X. A. Li, "How low is the α/beta; ratio for prostate cancer?" Int. J. Radiat. Oncol., Biol., Phys. 55, 194-203 (2003).
-
(2003)
Int. J. Radiat. Oncol., Biol., Phys.
, vol.55
, pp. 194-203
-
-
Wang, J.Z.1
Cuerrero, M.2
Li, X.A.3
-
15
-
-
0032520996
-
Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy
-
B. R. Prestidge, W. S. Bice, E. J. Kiefer, and J. J. Prete, "Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 40, 1111-1115 (1998).
-
(1998)
Int. J. Radiat. Oncol., Biol., Phys.
, vol.40
, pp. 1111-1115
-
-
Prestidge, B.R.1
Bice, W.S.2
Kiefer, E.J.3
Prete, J.J.4
-
16
-
-
0031950541
-
Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy
-
G. S. Merrick, W. M. Butler, A. T. Dorsey, and H. L. Walbert, "Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy," Radiat. Oncol. Invest. 6, 182-190 (1998).
-
(1998)
Radiat. Oncol. Invest.
, vol.6
, pp. 182-190
-
-
Merrick, G.S.1
Butler, W.M.2
Dorsey, A.T.3
Walbert, H.L.4
-
17
-
-
0141576615
-
The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us?
-
J. Z. Wang, X. A. Li, C. X. Yu, and S. J. DiBiase, "The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us?" Int. J. Radiat. Oncol., Biol., Phys. 57, 1101-1108 (2003).
-
(2003)
Int. J. Radiat. Oncol., Biol., Phys.
, vol.57
, pp. 1101-1108
-
-
Wang, J.Z.1
Li, X.A.2
Yu, C.X.3
DiBiase, S.J.4
-
18
-
-
0142186650
-
How low is α/β ratio for prostate cancer?
-
H. B. Kal and M. P. R. Van Gellekom, "How low is α/β ratio for prostate cancer?" Int. J. Radiat. Oncol., Biol., Phys. 57, 1122-1130 (2003).
-
(2003)
Int. J. Radiat. Oncol., Biol., Phys.
, vol.57
, pp. 1122-1130
-
-
Kal, H.B.1
Van Gellekom, M.P.R.2
-
19
-
-
0034255971
-
A comment on proliferation rates in human prostate cancer
-
K. Haustermans and J. F. Fowler. "A comment on proliferation rates in human prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 48, 303 (2000).
-
(2000)
Int. J. Radiat. Oncol., Biol., Phys.
, vol.48
, pp. 303
-
-
Haustermans, K.1
Fowler, J.F.2
|